Strong Industry Focus As a nonprofit dedicated to improving T1D treatment and prevention, T1D Exchange actively collaborates with leading health organizations, presenting opportunities to offer innovative healthcare solutions, data management tools, or technology platforms that support research and clinical care improvements.

Partnership Expansion Recent partnerships with the American Diabetes Association and Medtronic highlight T1D Exchange’s openness to strategic collaborations, making it a prime target for expanding technology integrations, data analytics services, or customized health equity solutions.

Recognition & Growth Receiving the 2023 President’s Award underscores the organization’s leadership in diabetes research and quality improvement, signaling potential for collaboration on cutting-edge projects, digital health tools, or educational platforms aimed at advancing diabetes care.

Research-Driven Approach With ongoing research initiatives like the diabetes pilot programs and focus on health equity, T1D Exchange is likely a receptive partner for advanced data collection technologies, patient engagement platforms, and analytics solutions to further enhance their research capabilities.

Financial Stability Generating revenue between $10M and $25M within the healthcare nonprofit sector indicates a stable budget environment, suggesting readiness to invest in innovative health technologies, data infrastructure, or partnership programs that align with their mission and growth strategies.